# CytoSolv

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/cytosolv

- Industry: Biotechnology
- Headquarters: Tiverton, US
- Website: www.cytosolv.com
- Total disclosed funding: $0.5M
- Latest round: Seed (Feb 9, 2010)
- Investors on record: 1

## About

CytoSolv is based in Tiverton, US and is developing proprietary technology to address wound healing, initially targeting diabetic ulcers. Its technology involves a mixture of wound-healing factors derived from porcine choroid plexus (CP), a key component of the blood brain barrier, which naturally secretes a variety of proteins into the cerebrospinal fluid responsible for growth, differentiation, nurturing and maintenance of the healing function.

## Funding rounds

- Seed, Feb 9, 2010, $0.5M — Slater Technology Fund

## Investors

- Slater Technology Fund (https://capitalatlas.ai/funds/slater-technology-fund) — Seed